3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Myeloid
11
Other hematologic neoplasm
10
Lymphoid
4
Plasma cell
1
Classical hematology
1
Conditions
Multiple Myeloma
20
Lymphoma
5
Neoplasms, Plasma Cell
4
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, Follicular
2
Hodgkin Disease
2
Smoldering Multiple Myeloma
1
Sarcoma
1
Paraproteinemias
1
Neoplasm, Residual
1
Myelodysplastic Syndromes
1
Monoclonal Gammopathy of Undetermined Significance
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Extranodal NK-T-Cell
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphoma, B-Cell
1
Leukemia, Myeloid, Acute
1
Immunoglobulin Light-chain Amyloidosis
1
Immunoblastic Lymphadenopathy
1
Hematologic Neoplasms
1
Disease
1
Carcinoma
1
Amyloidosis
1
Alzheimer Disease
1
Interventions
Cyclophosphamide
89
fludarabine phosphate
77
Mycophenolic Acid
53
Tacrolimus
52
Peripheral Blood Stem Cell Transplantation
50
Busulfan
44
Whole-Body Irradiation
43
Antilymphocyte Serum
41
fludarabine
37
Cyclosporine
36
Filgrastim
32
Melphalan
27
Methotrexate
26
Radiotherapy
23
Cord Blood Stem Cell Transplantation
19
Methylprednisolone
18
Granulocyte Colony-Stimulating Factor
16
Sirolimus
14
Etoposide
13
Alemtuzumab
12
thymoglobulin
11
sargramostim
11
Stem Cell Transplantation
11
Rituximab
11
Thiotepa
9
Azacitidine
8
Cytarabine
7
Psychiatric Rehabilitation
6
Prednisone
6
Flow Cytometry
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Myelodysplastic Syndromes
×
Blood Specimen Collection
×
Plasma cell
×
Clear all
NCT05735704
2025-03-26
SANGUINE
JaxBio Ltd
Unknown
3,000 enrolled